Over the past decades, virus‐like particle (VLP)‐based gene therapy (GT) evolved as a
promising approach to cure inherited diseases or cancer. Tremendous costs due to …

Bispecific antibodies (bsAbs) are some of the most promising biotherapeutics due to the
versatility provided by their structure and functional features. bsAbs simultaneously bind two …

High-performance antibodies are core reagents for highly sensitive immunoassays. Herein,
based on a novel hapten, a hybridoma secreting the high-affinity anti-ethirimol monoclonal …

Glycosylation of IgG regulates the effector function of this antibody in the immune response.
Glycosylated IgG is a potent therapeutic used for both research and clinical purposes. While …

Rapidly producing drug-like antibody therapeutics for lead molecule discovery and
candidate optimization is typically accomplished by large-scale transient gene expression …

Lactate metabolism plays a critical role in mammalian cell bioprocessing, influencing
cellular performance and productivity. The transition from lactate production to consumption …

Antibody-based therapeutics and recombinant protein reagents are often produced in
mammalian expression systems, which provide human-like post-translational modifications …

Gene therapy is poised to transition from niche to mainstream medicine, with recombinant
adeno-associated virus (rAAV) as the vector of choice. However, robust, scalable …

Recombinant proteins have long been used in the pharmaceutical, chemical, and
agricultural industries. These proteins can be produced in hosts such as mammalian cells …

Serology assays are essential tools to mitigate the effect of COVID-19, help to identify
previous SARS-CoV-2 infections or vaccination, and provide data for surveillance and …